The first three tables are excerpted from AACE/ACE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM 2017 [Resource (1) below].
The rest of the tables and text excerpts are from the AMERICAN DIABETES ASSOCIATION STANDARDS OF MEDICAL CARE IN DIABETES—2017 [Resource (2) below].
And here are links to specific pages in this blog post:
- Goals For Glycemic Control, Glycemic Control Algorithm, and Profiles of Antidiabetic Medicines
- Relationship of Mean Glucose Levels To Hemoglobin A1C Levels, Summary of Glycemic Recommendations For Many Non Pregant Adults With Diabetes, Approach To the Management Of Hyperglycemia [meaning How To Chose the Hemoglobin A1C Goal Based On the Individual Patient Factor
- Hypoglycemia
- Pharmacologic Therapy For Type 2 Diabetes
- Insulin Therapy In Type 2 Diabetes
- Properties of Glucose Lowering Agents And Their Costs In Type 2 Diabetes
- Diabetes Medicines That Lower Cardiovascular Risk In Type 2 Diabetes
- Combination Injectable Therapy, Costs of Insulins
Resources:
(1) CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM – 2017 EXECUTIVE SUMMARY [PubMed Abstract] [Full Text HTML] [Full Text PDF]. Endocr Pract. 2017 Feb;23(2):207-238. doi: 10.4158/EP161682.CS. Epub 2017 Jan 17.
(2) AMERICAN DIABETES ASSOCIATION STANDARDS OF MEDICAL CARE IN DIABETES—2017 [Full Text PDF]. January 2017 Volume 40, Supplement 1.
(3) Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets – the TITRATETM study [PubMed Abstract] [Full Text HTML] [Full Text PDF]. Diabetes Obes Metab. 2009 Jun;11(6):623-31. doi: 10.1111/j.1463-1326.2009.01060.x.
